James Hassard $ARWR SEC Form 4 Insider Trading

James Hassard has filed a total of 1 insider trades in $ARWR since 2021. Their most recent trade was a sale of 3,625 shares, made on Jun 22, 2021. Their largest trade was a sale of 3,625 shares, made on Jun 22, 2021. We estimate that they now own 105,750 shares of $ARWR, worth an estimated $9.8 million.

Insider Trading at $ARWR

There have been a total of 221 insider trades reported at $ARWR since 2021, with 3,655 shares purchased and 2.2 million shares sold. The most active insider traders in $ARWR stock have been Christopher Richard Anzalone, Patrick O'Brien, and James C Hamilton. The most recent trade was a sale of 2,970 shares reported by Hongbo Lu (None), made on May 12, 2026.

$ARWR Executives and Stock Owners with Insider Trades

• Christopher Richard Anzalone, Chief Executive Officer

• Patrick O'Brien, COO and General Counsel

• James C Hamilton, Chief Medical Officer

• Kenneth Allen Myszkowski, Chief Financial Officer

• Patrick O'Brien, COO

• Martin Javier San, Chief Medical Officer

• James C Hamilton, Chief Discovery/Trans Medicine

• Patrick O'Brien, General Counsel

• Daniel Joseph Apel, Chief Financial Officer

• Tracie Oliver, Chief Commercial Officer

• James Hassard, Chief Commercial Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.